MDB Capital Holdings (MDBH) Q4 2024 earnings summary

Executive summary

• Successfully launched eXoZymes via IPO in November, spun out from UCLA, with MDB retaining 47% ownership, despite challenging small-cap IPO market conditions.

• Deconsolidation of eXoZymes from financials clarifies MDB's standalone performance and resulted in a significant gain on investment.

• Expanded investor community, increasing shareholder base by 12% and assets under management from $2M to $44M in 2024.

• Operational efficiencies achieved with the launch of MDB Direct and a new clearing platform, onboarding over 500 investors and completing its first full year serving MDB investors.

• Enhanced analyst team to 14, screening 8,964 companies and building a robust pipeline of potential "Big Ideas."

Financial highlights

• As of December 31, 2024: cash and securities totaled $28 million; eXoZymes investment valued at $64 million; total cash and securities at $93 million.

• Market value at year-end was $62 million with 9.9 million shares outstanding and a stock price of $630.

• Negative market value of $30 million, largely due to market volatility and eXoZymes' stock price fluctuations.

• Cash utilization for the year was $10.6 million, mainly invested in developing new big ideas.

• Filed Form 10-K with consolidated financial results, including eXoZymes' performance through its IPO on Nov 14, 2024, after which it was deconsolidated.

Outlook and guidance

• Expecting to present three to four new big idea companies in 2025, with some at advanced stages and potential IPOs as early as September.

• Strategic priority is expanding the investor base via RIAs and angel groups to support increased deal flow.

• Management expresses optimism about the public venture approach, citing strong investor and advisor support amid challenging venture capital markets.

• Anticipates operational cash outflows to decrease as revenue from fees and financings offset OpEx.

• Shareholder letter with detailed financials and further guidance to be released soon; ongoing initiatives and anticipated milestones to be discussed in the earnings call.